Glycophorin a as a biological dosimeter for radiation dose to the bone marrow from iodine-131

Radiation Research

Volumn 147, Issue 6, 1997, Pages 747-752

  Jensen, Ronald H ^a   Reynolds, James C ^b   Robbins, Jacob ^b   Bigbee, William L ^c   Grant, Stephen G ^c   Langlois, Richard G ^d   Pineda, J Desiree ^b   Lee, Taisheng ^b   Barker, W Craig ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A; IODINE 131;

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW CELL; CLINICAL ARTICLE; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DOSIMETRY; FEMALE; FLOW CYTOMETRY; GENETIC DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RADIATION DOSE; SOMATIC MUTATION; THYROID CANCER; WHOLE BODY RADIATION;

BONE MARROW; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GLYCOPHORIN; HUMANS; IODINE RADIOISOTOPES; MALE; RADIATION DOSAGE; THYROID NEOPLASMS;

EID: 0030979873     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579490     Document Type: Article

References (24)

1. R. G. Langlois, B. A. Nisbet, W. L. Bigbee, D. N. Ridinger and R. H. Jensen, An improved flow cytometric assay for somatic mutations at the glycophorin A locus in humans. Cytometry 11, 513-521 (1990).
2. R. G. Langlois, M. Akiyama, Y. Kusunoki, B. R. DuPont, D. H. Moore, II, W. L. Bigbee, S. G. Grant and R. H. Jensen, Analysis of somatic mutations and the glycophorin A locus in atomic bomb survivors: A comparative study of assay methods. Radiat. Res. 136, 111-117 (1993).
3. R. H. Jensen, R. G. Langlois, S. G. Grant and W. L. Bigbee, Biodosimetry of ionizing radiation in humans using the glycophorin A genotoxicity assay. In Radiation Research: A Twentieth-Century Perspective, Vol. 2 (W. C. Dewey, M. Edington, R. J. M. Fry, E. J. Hall and G. F. Whitmore, Eds.), pp. 172-176. Academic Press, San Diego, 1992.
4. S. G. Grant and R. H. Jensen, Use of hematopoietic cells and markers for the detection and quantitation of human in vivo somatic mutations. In Immunology of Transfusion Medicine (G. Garraty, Ed.), pp. 299-323. Marcel Dekker, New York, 1993.
5. R. H. Jensen, R. G. Langlois, W. L. Bigbee, S. G. Grant, D. N. Moore, M. Pilinskaya, I. Vorobtsova and P. Pleshanov, Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat. Res. 141, 129-135 (1995).
6. J. Robbins, M. J. Merino, J. D. Boice, E. Ron, K. B. Ain, H. R. Alexander, J. A. Norton and J. Reynolds, Thyroid cancer: A lethal endocrine neoplasm. Ann. Intern. Med. 115, 133-147 (1991).
7. R. S. Benua, N. R. Cicale, M. Sonenberg and R. W. Rawson. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am. J. Roentgenol. 87, 171-182 (1962).
8. J. E. Rall, C. G. Foster, J. Robbins, R. Lazerson, L. E. Farr and R. W. Rawson, Dosimetric considerations in determining hematopoietic damage from radioactive iodine. Am. J. Roentgenol. 70, 274-282 (1953).
9. E. G. Movius, J. Robbins, L. R. Pierce, J. C. Reynolds, A. Keenan and M. A. Phyillaier, The value of lithium in radioiodine therapy of thyroid carcinoma. In Frontiers in Thyroidology (G. Medeiros-Neto and E. Gaitan, Eds.), pp. 1269-1272. Plenum, New York, 1986.
10. R. Loevinger and M. Berman, A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides. MIRD Pamphlet no. 1 (revised). Society of Nuclear Medicine, New York, 1976.
11. W. S. Snyder, M. R. Ford and G. G. Warner, "S", Absorbed Dose Per Unit Cumulated Activity for Selected Radionuclides and Organs. MIRD Pamphlet no. 11, Society of Nuclear Medicine, New York, 1975.
12. J. A. Siegel, B. W. Wessels, E. E. Watson, M. G. Stabin, H. M. Vriesendorp, E. W. Bradley, C. C. Badger, A. B. Brill, C. S. Kwok, D. R. Stickney, K. F. Eckerman, D. R. Fisher, D. J. Buchsbaum and S. E. Order, Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconjugates Radiopharm. 3, 213-233 (1990).
13. L. T. Dillman and F. C. Van der Loge, Radionuclide Decay Schemes and Nuclear Parameters for Use in Radiation-Dose Estimation. MIRD Pamphlet no. 10, Society of Nuclear Medicine, New York, 1975.
14. J. A. Retzlaff, W. N. Tauxe, J. M. Kiely and C. F. Stroebel, Erythrocyte volume, plasma volume, and lean body mass in adult men and women. Blood 33, 649-661 (1969).
15. J. L. Coffey and E. E. Watson, Calculating dose from remaining body activity: A comparison of two methods. Med. Phys. 6, 307-308 (1979).
16. 3H]TdR incorporated in the DNA of human lymphoblast cells. Mutat. Res. 111, 387-404 (1983).
17. J. Hoeijmakers and D. Bootsma, Molecular genetics of eukaryotic DNA excision repair. Cancer Cells 2, 311-320 (1990).
18. A. Skandalis, J. Curry, J. P. O'Neill, J. A. Nicklas, R. J. Albertini and B. W. Glickman, Analysis of point mutations in the hprt gene of cancer patients treated with radioimmunoglobulin therapy. Environ. Mol. Mutagen. 26, 213-217 (1995).
19. J. P. O'Neill, T. C. Hunter, L. M. Sullivan, J. A. Nicklas and R. J. Albertini, Southern-blot analyses of human T-lymphocyte mutants induced in vitro by gamma-irradiation. Mutat. Res. 240, 143-149 (1990).
20. J. A. Nicklas, J. P. O'Neill, T. C. Hunter, M. T. Falta, M. J. Lippert, D. Jacobson-Kram, J. R. Williams and R. J. Albertini, In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes. Mutat. Res. 250, 383-396 (1991).
21. I. A. Likhtarev, N. K. Shandala, G. M. Gulko, I. A. Kairo and N. I. Chepurny, Ukrainian thyroid doses after the Chernobyl accident. Health Phys. 64, 594-599 (1993).
22. I. A. Likhtarev, G. M. Gulko, I. A. Kairo, K. Henrichs and H. G. Paretzke, Thyroid doses resulting from the Ukraine Chernobyl accident - Part I: Dose estimates for the population of Kiev. Health Phys. 66, 137-146 (1994).
23. 131I thyroid measurements and extrapolation of the results to districts without monitoring. Radiat. Environ. Biophys. 33, 149-166 (1994).
24. 131I thyroid-monitoring measurements performed in Ukraine during May and June of 1986. Health Phys. 69, 6-15 (1995).